Toxicological Research

Korean Society of Toxicology & Korea Environmental Mutagen Society (한국독성학회)
권호 표지
DOI QR코드

DOI QR Code

Methylated Organic Metabolites of Arsenic and their Cardiovascular Toxicities

  • Bae, Ok-Nam (College of Pharmacy, Institute of Pharmaceutical Sciences, Seoul National University) ;
  • Lim, Kyung-Min (College of Pharmacy, Institute of Pharmaceutical Sciences, Seoul National University) ;
  • Noh, Ji-Yoon (College of Pharmacy, Institute of Pharmaceutical Sciences, Seoul National University) ;
  • Kim, Keun-Young (College of Pharmacy, Institute of Pharmaceutical Sciences, Seoul National University) ;
  • Lim, Eun-Kyung (College of Pharmacy, Institute of Pharmaceutical Sciences, Seoul National University) ;
  • Chung, Jin-Ho (College of Pharmacy, Institute of Pharmaceutical Sciences, Seoul National University)
  • Published : 2008.09.01
Download PDF
⟨ Previous Next ⟩

Abstract

Recently, arsenic-toxicity has become the major focus of strenuous assessment and dynamic research from the academy and regulatory agency. To elucidate the cause and the mechanism underlying the serious adverse health effects from chronic ingestion of arsenic-contaminated drinking water, numerous studies have been directed on the investigation of arsenic-toxicity using various in vitro as well as in vivo systems. Neverthless, some questions for arsenic effects remain unexplained, reflecting the contribution of unknown factors to the manifestation of arsenic-toxicity. Interestingly, very recent studies on arsenic metabolites have discovered that trivalent methylated arsenicals show stronger cytotoxic and genotoxic potentials than inorganic arsenic or pentavalent metabolites, arguing that these metabolites could play a key role in arsenic-associated disorders. In this review, recent progress and literatures are summarized on the metabolism of trivalent methylated metabolites and their toxicity on body systems including cardiovascular system in an effort to provide an insight into the future research on arsenic-associated disorders.

Keywords

References

  1. Abernathy, C.O., Thomas, D.J. and Calderon, R.L. (2003). Health effects and risk assessment of arsenic. J. Nutr., 133, 1536S-1538S
  2. Aposhian, H.V. (1997). Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu. Rev. Pharmacol. Toxicol., 37, 397-419 https://doi.org/10.1146/annurev.pharmtox.37.1.397
  3. Aposhian, H.V., Gurzau, E.S., Le, X.C., Gurzau, A., Healy, S.M., Lu, X., Ma, M., Yip, L., Zakharyan, R.A., Maiorino, R.M., Dart, R.C., Tircus, M.G., Gonzalez-Ramirez, D., Morgan, D.L., Avram, D. and Aposhian, M.M. (2000a). Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem. Res. Toxicol., 13, 693-697 https://doi.org/10.1021/tx000114o
  4. Aposhian, H.V., Zheng, B., Aposhian, M.M., Le, X.C., Cebrian, M.E., Cullen, W., Zakharyan, R.A., Ma, M., Dart, R.C., Cheng, Z., Andrewes, P., Yip, L., O'Malley, G.F., Maiorino, R.M., Van Voorhies, W., Healy, S.M. and Titcomb, A. (2000b). DMPS-arsenic challenge test. II. Modulation of arsenic species, including monomethylarsonous acid (MMA(III)), excreted in human urine. Toxicol. Appl. Pharmacol., 165, 74-83 https://doi.org/10.1006/taap.2000.8922
  5. Aposhian, H.V., Zakharyan, R.A., Avram, M.D., Sampayo- Reyes, A. and Wollenberg, M.L. (2004). A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species. Toxicol. Appl. Pharmacol., 198, 327-335 https://doi.org/10.1016/j.taap.2003.10.027
  6. Bae, O.N., Lim, E.K., Lim, K.M., Noh, J.Y., Chung, S.M., Lee, M.Y., Yun, Y.P., Kwon, S.C., Lee, J.H., Nah, S.Y., and Chung, J.H. (2008). Vascular smooth muscle dysfunction induced by monomethylarsonous acid ($MMA^{III}$): A contributing factor to arsenic-associated cardiovascular diseases. Environ. Res., doi:10.1016/j.envres.2008.06.012
  7. Bae, O.N., Lim, K.M., Noh, J.Y., Chung, S.M., Kim, H., Lee, C.R., Park, J.D. and Chung, J.H. (2007). Arsenite-enhanced procoagulant activity through phosphatidylserine exposure in platelets. Chem. Res. Toxicol., 20, 1760-1768 https://doi.org/10.1021/tx700159y
  8. Bates, M.N., Smith, A.H. and Hopenhayn-Rich, C. (1992). Arsenic ingestion and internal cancers: a review. Am. J. Epidemiol., 135, 462-476 https://doi.org/10.1093/oxfordjournals.aje.a116313
  9. Berg, M., Tran, H.C., Nguyen, T.C., Pham, H.V., Schertenleib, R. and Giger, W. (2001). Arsenic contamination of groundwater and drinking water in Vietnam: a human health threat. Environ. Sci. Technol., 35, 2621-2626 https://doi.org/10.1021/es010027y
  10. Bhattacharyya, R., Chatterjee, D., Nath, B., Jana, J., Jacks, G. and Vahter, M. (2003). High arsenic groundwater: mobilization, metabolism and mitigation--an overview in the Bengal Delta Plain. Mol. Cell. Biochem., 253, 347-355 https://doi.org/10.1023/A:1026001024578
  11. Buchet, J.P., Lauwerys, R. and Roels, H. (1981). Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. Int. Arch. Occup. Environ. Health, 48, 71-79 https://doi.org/10.1007/BF00405933
  12. Buchet, J.P., Pauwels, J. and Lauwerys, R. (1994). Assessment of exposure to inorganic arsenic following ingestion of marine organisms by volunteers. Environ. Res., 66, 44-51 https://doi.org/10.1006/enrs.1994.1043
  13. Bunderson, M., Brooks, D.M., Walker, D.L., Rosenfeld, M.E., Coffin, J.D. and Beall, H.D. (2004). Arsenic exposure exacerbates atherosclerotic plaque formation and increases nitrotyrosine and leukotriene biosynthesis. Toxicol. Appl. Pharmacol., 201, 32-39 https://doi.org/10.1016/j.taap.2004.04.008
  14. Caceres, D.D., Pino, P., Montesinos, N., Atalah, E., Amigo, H. and Loomis, D. (2005). Exposure to inorganic arsenic in drinking water and total urinary arsenic concentration in a Chilean population. Environ. Res., 98, 151-159 https://doi.org/10.1016/j.envres.2005.02.007
  15. Cebrian, M.E., Albores, A., Aguilar, M. and Blakely, E. (1983). Chronic arsenic poisoning in the north of Mexico. Hum. Toxicol., 2, 121-133 https://doi.org/10.1177/096032718300200110
  16. Chouchane, S. and Snow, E.T. (2001). In vitro effect of arsenical compounds on glutathione-related enzymes. Chem. Res. Toxicol., 14, 517-522 https://doi.org/10.1021/tx000123x
  17. Concha, G., Vogler, G., Lezcano, D., Nermell, B. and Vahter, M. (1998). Exposure to inorganic arsenic metabolites during early human development. Toxicol. Sci., 44, 185-190 https://doi.org/10.1093/toxsci/44.2.185
  18. Cullen, W.R., McBride, B.C. and Reglinski, J. (1984). The reaction of methylarsenicals with thiols: Some biological implications. J. Inorg. Biochem., 21, 179-194 https://doi.org/10.1016/0162-0134(84)83002-0
  19. Del Razo, L.M., Styblo, M., Cullen, W.R. and Thomas, D.J. (2001). Determination of trivalent methylated arsenicals in biological matrices. Toxicol. Appl. Pharmacol., 174, 282-293 https://doi.org/10.1006/taap.2001.9226
  20. Edmonds, J.S., Shibata, Y., Francesconi, K.A., Rippingale, R.J. and Moritaet, M. (1997). Arsenic transformations in short marine food chains studied by HPLC-ICP MS. Appl. Organomet. Chem., 11, 281-287 https://doi.org/10.1002/(SICI)1099-0739(199704)11:4<281::AID-AOC581>3.0.CO;2-S
  21. Eguchi, N., Kuroda, K. and Endo, G. (1997). Metabolites of arsenic induced tetraploids and mitotic arrest in cultured cells. Arch. Environ. Contam. Toxicol., 32, 141-145 https://doi.org/10.1007/s002449900166
  22. Gebel, T.W. (1999). Arsenic and drinking water contamination. Science, 283, 1458-1459
  23. Gregus, Z. and Nemeti, B. (2002). Purine nucleoside phosphorylase as a cytosolic arsenate reductase. Toxicol. Sci., 70, 13-19 https://doi.org/10.1093/toxsci/70.1.13
  24. Hasegawa, H., Sohrin, Y., Matsui, M., Hojo, M. and Kawashima, M. (1994). Speciation of arsenic in natural waters by solvent extraction and hydride generation atomic absorption spectrometry. Anal. Chem., 66, 3247-3252 https://doi.org/10.1021/ac00091a039
  25. Hayakawa, T., Kobayashi, X., Cui, X. and Hirano, S. (2005). A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19. Arch. Toxicol., 79, 183-191 https://doi.org/10.1007/s00204-004-0620-x
  26. Heydorn, K. (1970). Environmental variation of arsenic levels in human blood determines by neutron activation analysis. Clin. Chim. Acta, 28, 349-357 https://doi.org/10.1016/0009-8981(70)90101-4
  27. Hirano, S., Cui, X., Li, S., Kanno, S., Kobayashi, Y., Hayakawa, T. and Shraim, A. (2003). Difference in uptake and toxicity of trivalent and pentavalent inorganic arsenic in rat heart microvessel endothelial cells. Arch. Toxicol., 77, 305-312 https://doi.org/10.1007/s00204-003-0447-x
  28. Hirano, S., Kobayashi, Y., Cui, X., Kanno, S., Hayakawa, T. and Shraim, A. (2004). The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds. Toxicol. Appl. Pharmacol., 198, 458-467 https://doi.org/10.1016/j.taap.2003.10.023
  29. Hopenhayn-Rich, C., Biggs, M.L., Fuchs, A., Bergoglio, R., Tello, E.E., Nicolli, H. and Smith, A.H. (1996). Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology, 7, 117-124 https://doi.org/10.1097/00001648-199603000-00003
  30. Hughes, M.F., Devesa, V., Adair, B.M., Conklin, S.D., Creed, J.T., Styblo, M., Kenyon, E.M. and Thomas, D.J. (2008). Tissue dosimetry, metabolism and excretion of pentavalent and trivalent dimethylated arsenic in mice after oral administration. Toxicol. Appl. Pharmacol., 227, 26-35 https://doi.org/10.1016/j.taap.2007.10.011
  31. Jan, K.Y., Wang, T.C., Ramanathan, B. and Gurr, J.R. (2006). Dithiol compounds at low concentrations increase arsenite toxicity. Toxicol. Sci., 90, 432-439 https://doi.org/10.1093/toxsci/kfj108
  32. Kligerman, A.D., Doerr, C.L., Tennant, A.H., Harrington-Brock, K., Allen, J.W., Winkfield, E., Poorman-Allen, P., Kundu, B., Funasaka, K., Roop, B.C., Mass, M.J. and DeMarini, D.M. (2003). Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: induction of chromosomal mutations but not gene mutations. Environ. Mol. Mutagen., 42, 192-205 https://doi.org/10.1002/em.10192
  33. Kruger, K., Repges, H., Hippler, J., Hartmann, L.M., Hirner, A.V., Straub, H., Binding, N. and Musshoff, U. (2007). Effects of dimethylarsinic and dimethylarsinous acid on evoked synaptic potentials in hippocampal slices of young and adult rats. Toxicol. Appl. Pharmacol., 225, 40-46 https://doi.org/10.1016/j.taap.2007.07.007
  34. Kumagai, Y. and Pi, J. (2004). Molecular basis for arsenicinduced alteration in nitric oxide production and oxidative stress: implication of endothelial dysfunction. Toxicol. Appl. Pharmacol., 198, 450-457 https://doi.org/10.1016/j.taap.2003.10.031
  35. Kwok, R.K., Mendola, P., Liu, Z.Y., Savitz, D.A., Heiss, G., Ling, H.L., Xia, Y., Lobdell, D., Zeng, D., Thorp, J.M. Jr., Creason, J.P. and Mumford, J.L. (2007). Drinking water arsenic exposure and blood pressure in healthy women of reproductive age in Inner Mongolia, China. Toxicol. Appl. Pharmacol., 222, 337-343 https://doi.org/10.1016/j.taap.2007.04.003
  36. Lamm, S.H., Engel, A., Kruse, M.B., Feinleib, M., Byrd, D.M., Lai, S. and Wilson, R. (2004). Arsenic in drinking water and bladder cancer mortality in the United States: an analysis based on 133 U.S. counties and 30 years of observation. J. Occup. Environ. Med., 46, 298-306 https://doi.org/10.1097/01.jom.0000116801.67556.8f
  37. Le, X.C., Lu, X., Ma, M., Cullen, W.R., Aposhian, H.V. and Zheng, B. (2000a). Speciation of key arsenic metabolic intermediates in human urine. Anal. Chem., 72, 5172-5177 https://doi.org/10.1021/ac000527u
  38. Le, X.C., Ma, M., Cullen, W.R., Aposhian, H.V., Lu, X. and Zheng, B. (2000b). Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ. Health Perspect, 108, 1015-1018 https://doi.org/10.2307/3434951
  39. Lee, T.C., Tanaka, N., Lamb, P.W., Gilmer, T.M. and Barrett, J.C. (1988). Induction of gene amplification by arsenic. Science, 241, 79-81 https://doi.org/10.1126/science.3388020
  40. Lee, M.Y., Bae, O.N., Chung, S.M., Kang, K.T., Lee, J.Y. and Chung, J.H. (2002). Enhancement of platelet aggregation and thrombus formation by arsenic in drinking water: a contributing factor to cardiovascular disease. Toxicol. Appl. Pharmacol., 179, 83-88 https://doi.org/10.1006/taap.2001.9356
  41. Lee, M.Y., Jung, B.I., Chung, S.M., Bae, O.N., Lee, J.Y., Park, J.D., Yang, J.S., Lee, H. and Chung, J.H. (2003). Arsenic-induced dysfunction in relaxation of blood vessels. Environ. Health Perspect., 111, 513-517
  42. Lee, M.Y., Lee, Y.H., Lim, K.M., Chung, S.M., Bae, O.N., Kim, H., Lee, C.R., Park, J.D. and Chung, J.H. (2005). Inorganic arsenite potentiates vasoconstriction through calcium sensitization in vascular smooth muscle. Environ. Health Perspect., 113, 1330-1335 https://doi.org/10.1289/ehp.8000
  43. Lewis, D.R., Southwick, J.W., Ouellet-Hellstrom, R., Rench, J. and Calderon, R.L. (1999). Drinking water arsenic in Utah: A cohort mortality study. Environ. Health Perspect, 107, 359-365 https://doi.org/10.2307/3434539
  44. Li, B., Sun, Y., Sun, X., Wang, Y., Li, X., Kumagai, Y. and Sun, G. (2007). Monomethylarsonous acid induced cytotoxicity and endothelial nitric oxide synthase phosphorylation in endothelial cells. Bull. Environ. Contam. Toxicol., 78, 455-458 https://doi.org/10.1007/s00128-007-9178-7
  45. Lin, S., Del Razo, L.M., Styblo, M., Wang, C., Cullen, W.R. and Thomas, D.J. (2001). Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes. Chem. Res. Toxicol., 14, 305-311 https://doi.org/10.1021/tx0001878
  46. Liu, Z., Shen, J., Carbrey, J.M., Mukhopadhyay, R., Agre, P. and Rosen, B.P. (2002). Arsenite transport by mammalian aquaglyceroporins AQP7 and AQP9. Proc. Natl. Acad. Sci. USA, 99, 6053-6058
  47. Mandal, B.K., Ogra, Y., Anzai, K. and Suzuki, K.T. (2004). Speciation of arsenic in biological samples. Toxicol. Appl. Pharmacol., 198, 307-318 https://doi.org/10.1016/j.taap.2003.10.030
  48. Mass, M.J., Tennant, A., Roop, B.C., Cullen, W.R., Styblo, M., Thomas, D.J. and Kligerman, A.D. (2001). Methylated trivalent arsenic species are genotoxic. Chem. Res. Toxicol., 14, 355-361 https://doi.org/10.1021/tx000251l
  49. Mead, M.N. (2005). Arsenic: in search of an antidote to a global poison. Environ. Health Perspect, 113, A378-386 https://doi.org/10.1289/ehp.113-a378
  50. Nemeti, B. and Gregus, Z. (2002). Mitochondria work as reactors in reducing arsenate to arsenite. Toxicol. Appl. Pharmacol., 182, 208-218 https://doi.org/10.1006/taap.2002.9443
  51. Nesnow, S., Roop, B.C., Lambert, G., Kadiiska, M., Mason, R.P., Cullen, W.R. and Mass, M.J. (2002). DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species. Chem. Res. Toxicol., 15, 1627-1634 https://doi.org/10.1021/tx025598y
  52. Olguin, A., Jauge, P., Cebrian, M. and Albores, A. (1983). Arsenic levels in blood, urine, hair and nails from a chronically exposed human population. Proc. West Pharmacol. Soc., 26, 175-177
  53. Oremland, R.S. and Stolz, J.F. (2003). The ecology of arsenic. Science, 300, 939-944 https://doi.org/10.1126/science.1081903
  54. Petrick, J.S., Ayala-Fierro, F., Cullen, W.R., Carter, D.E. and Aposhian, H.V. (2000). Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol., 163, 203-207 https://doi.org/10.1006/taap.1999.8872
  55. Petrick, J.S., Jagadish, B., Mash, E.A. and Aposhian, H.V. (2001). Monomethylarsonous acid (MMA(III)) and arsenite: LD(50) in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem. Res. Toxicol., 14, 651-656 https://doi.org/10.1021/tx000264z
  56. Pi, J., Kumagai, Y., Sun, G., Yamauchi, H., Yoshida, T., Iso, H., Endo, A., Yu, L., Yuki, K., Miyauchi, T. and Shimojo, N. (2000). Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in inner Mongolia. Free Radic. Biol. Med., 28, 1137-1142 https://doi.org/10.1016/S0891-5849(00)00209-4
  57. Radabaugh, T.R. and Aposhian, H.V. (2000). Enzymatic reduction of arsenic compounds in mammalian systems: reduction of arsenate to arsenite by human liver arsenate reductase. Chem. Res. Toxicol., 13, 26-30 https://doi.org/10.1021/tx990115k
  58. Sakurai, T., Qu, W., Sakurai, M.H. and Waalkes, M.P. (2002). A major human arsenic metabolite, dimethylarsinic acid, requires reduced glutathione to induce apoptosis. Chem. Res. Toxicol., 15, 629-637 https://doi.org/10.1021/tx0101604
  59. Sampayo-Reyes, A., Zakharyan, R.A., Healy, S.M. and Aposhian, H.V. (2000). Monomethylarsonic acid reductase and monomethylarsonous acid in hamster tissue. Chem. Res. Toxicol., 13, 1181-1186 https://doi.org/10.1021/tx000154s
  60. Shiobara, Y., Ogra, Y. and Suzuki, K.T. (2001). Animal species difference in the uptake of dimethylarsinous acid (DMA(III)) by red blood cells. Chem. Res. Toxicol., 14, 1446-1452 https://doi.org/10.1021/tx015537k
  61. Simeonova, P.P., Hulderman, T., Harki, D. and Luster, M.I. (2003). Arsenic exposure accelerates atherogenesis in apolipoprotein E(-/-) mice. Environ. Health Perspect., 111, 1744-1748 https://doi.org/10.1289/ehp.6332
  62. Simeonova, P.P. and Luster, M.I. (2004). Arsenic and atherosclerosis. Toxicol. Appl. Pharmacol., 198, 444-449 https://doi.org/10.1016/j.taap.2003.10.018
  63. Smedley P.L. and Kinniburgh D.G. (2002). A review of the source, behaviour and distribution of arsenic in natural waters. Appl. Geochem., 17, 517-568 https://doi.org/10.1016/S0883-2927(02)00018-5
  64. Soucy, N.V., Klei, L.R., Mayka, D.D. and Barchowsky, A. (2004). Signaling pathways for arsenic-stimulated vascular endothelial growth factor-a expression in primary vascular smooth muscle cells. Chem. Res. Toxicol., 17, 555-563 https://doi.org/10.1021/tx034193q
  65. Styblo, M., Del Razo, L.M., Vega, L., Germolec, D.R., LeCluyse, E.L., Hamilton, G.A., Reed, W., Wang, C., Cullen, W.R. and Thomas, D.J. (2000). Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol., 74, 289-299 https://doi.org/10.1007/s002040000134
  66. Styblo, M., Drobna, Z., Jaspers, I., Lin, S. and Thomas, D.J. (2002). The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Environ. Health Perspect., 110 Suppl 5, 767-771 https://doi.org/10.1289/ehp.02110s5767
  67. Styblo, M., Serves, S.V., Cullen, W.R. and Thomas, D.J. (1997). Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols. Chem. Res. Toxicol., 10, 27-33 https://doi.org/10.1021/tx960139g
  68. Suzuki, K.T., Tomita, T., Ogra, Y. and Ohmichi, M. (2001). Glutathione-conjugated arsenics in the potential hepato enteric circulation in rats. Chem. Res. Toxicol., 14, 1604-1611 https://doi.org/10.1021/tx0155496
  69. Tseng, C.H., Chong, C.K., Tseng, C.P., Hsueh, Y.M., Chiou, H.Y., Tseng, C.C. and Chen, C.J. (2003). Long-term arsenic exposure and ischemic heart disease in arseniasis- hyperendemic villages in Taiwan. Toxicol. Lett., 137, 15-21 https://doi.org/10.1016/S0378-4274(02)00377-6
  70. Tsou, T.C., Tsai, F.Y., Wu, M.C. and Chang, L.W. (2003). The protective role of NF-kappaB and AP-1 in arsenite-induced apoptosis in aortic endothelial cells. Toxicol. Appl. Pharmacol., 191, 177-187 https://doi.org/10.1016/S0041-008X(03)00239-4
  71. Vahter, M. (2002). Mechanisms of arsenic biotransformation. Toxicology, 181-182, 211-217 https://doi.org/10.1016/S0300-483X(02)00285-8
  72. Vahter, M. and Marafante, E. (1983). Intracellular interaction and metabolic fate of arsenite and arsenate in mice and rabbits. Chem. Biol. Interact., 47, 29-44 https://doi.org/10.1016/0009-2797(83)90145-X
  73. Valenzuela, O.L., Borja-Aburto, V.H., Garcia-Vargas, G.G., Cruz-Gonzalez, M.B., Garcia-Montalvo, E.A., Calderon- Aranda, E.S. and Del Razo, L.M. (2005). Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic. Environ. Health Perspect., 113, 250-254 https://doi.org/10.1289/ehp.113-a250
  74. Wildfang, E., Radabaugh, T.R. and Aposhian, H.V. (2001). Enzymatic methylation of arsenic compounds. IX. Liver arsenite methyltransferase and arsenate reductase activities in primates. Toxicology, 168, 213-221 https://doi.org/10.1016/S0300-483X(01)00481-4
  75. Xia, Y. and Liu, J. (2004). An overview on chronic arsenism via drinking water in PR China. Toxicology, 198, 25-29 https://doi.org/10.1016/j.tox.2004.01.016
  76. Yoshida, T., Yamauchi, H. and Fan Sun, G. (2004). Chronic health effects in people exposed to arsenic via the drinking water: dose-response relationships in review. Toxicol. Appl. Pharmacol., 198, 243-252 https://doi.org/10.1016/j.taap.2003.10.022
  77. Yu, H.S., Lee, C.H. and Chen, G.S. (2002). Peripheral vascular diseases resulting from chronic arsenical poisoning. J. Dermatol., 29, 123-130 https://doi.org/10.1111/j.1346-8138.2002.tb00234.x
  78. Zakharyan, R.A. and Aposhian, H.V. (1999). Arsenite methylation by methylvitamin B12 and glutathione does not require an enzyme. Toxicol. Appl. Pharmacol., 154, 287-291 https://doi.org/10.1006/taap.1998.8587